Suchergebnisse - "Labadie, Brian W"

PubPharm (13)

1

Lung Transplantation for Pulmonary AL Amyloidosis

enthalten in: Transplantation direct | 2024

von Ehrlich, M. | Hughes, M. | Labadie, B. | +5

2

Mitotane and the myth of 14 mg/L

enthalten in: The Lancet. Oncology | 2024

von Ehrlich, M. | Labadie, B. | Bates, S. | +1

3

In Defense of Neuroendocrine Tumor Trials-Reply

enthalten in: JAMA oncology | 2023

von Labadie, B. | Fojo, A.

4

Requirements for Meaningful Progress in the Therapy of Neuroendocrine Cancers

enthalten in: JAMA oncology | 2023

von Labadie, B. | Fojo, A.

5

Guidelines for Management of Treatment-Emergent Adverse Events During Rucaparib Treatment of Patients with Metastatic Castration-Resistant Prostate Cancer

enthalten in: Cancer management and research | 2022

von Labadie, B. | Morris, D. | Bryce, A. | +5

6

Immune Checkpoint Inhibitors for Genitourinary Cancers : Treatment Indications, Investigational Approaches and Biomarkers

enthalten in: Cancers | 2021

von Labadie, B. | Balar, A. | Luke, J.

7

Targeting Innate Immunity in Cancer Therapy

enthalten in: Vaccines | 2021

von Rameshbabu, S. | Labadie, B. | Argulian, A. | +1

8

Transcriptional analysis of metastatic uveal melanoma survival nominates NRP1 as a therapeutic target

enthalten in: Melanoma research | 2021

von Bao, R. | Surriga, O. | Olson, D. | +13

9

Randomized Phase II Trial and Tumor Mutational Spectrum Analysis from Cabozantinib versus Chemotherapy in Metastatic Uveal Melanoma (Alliance A091201)

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2020

von Luke, J. | Olson, D. | Allred, J. | +10

10

BMI, irAE, and gene expression signatures associate with resistance to immune-checkpoint inhibition and outcomes in renal cell carcinoma

enthalten in: Journal of translational medicine | 2019

von Labadie, B. | Liu, P. | Bao, R. | +9